Table 6.
Types of adverse events of the individual brands of COVID-19 vaccines (participants may report more than 1 reaction; n = 288 participants)
| Adverse events | Brand of Vaccine | |||||
|---|---|---|---|---|---|---|
| CoronaVac (Sinovac) | AZD1222 (Oxford/ AstraZeneca) | Sputnik V (Gamaleya) | Ad26.COV2.S (Janssen) | BNT162b2 (Pfizer/BioNTech) | mRNA-1273 (Moderna) | |
| N = 324 doses | N = 131 doses | N = 22 doses | N = 9 doses | N = 165 doses | N = 130 doses | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Systemic Reactions | ||||||
| Drowsiness | 16 (4.9) | 0 | 1 (4.5) | 0 | 0 | 1 (0.8) |
| Headache | 16 (4.9) | 14 (10.7) | 4 (18.2) | 0 | 11 (6.7) | 19 (14.6) |
| Body pain/myalgia | 8 (2.5) | 24 (18.3) | 1 (4.5) | 1 (11.1) | 19 (11.5) | 31 (23.8) |
| Fatigue | 8 (2.5) | 11 (8.4) | 1 (4.5) | 1 (11.1) | 8 (4.8) | 22 (16.9) |
| Fever | 3 (0.9) | 40 (30.5) | 4 (18.2) | 1 (11.1) | 15 (9.1) | 40 (30.8) |
| Diarrhea | 1 (0.3) | 0 | 0 | 0 | 1 (0.6) | 0 |
| Chills | 1 (0.3) | 6 (4.6) | 1 (4.5) | 0 | 3 (1.8) | 5 (3.8) |
| Nausea | 0 | 0 | 0 | 0 | 1 (0.6) | 2 (1.5) |
| Local Reactions | ||||||
| Pain at injection Site | 56 (17.3) | 25 (19.1) | 9 (40.9) | 2 (22.2) | 41 (25.9) | 30 (23.1) |
| Arm heaviness | 20 (6.2) | 3 (2.3) | 0 | 0 | 8 (4.9) | 8 (6.2) |
*Denominator is total number of doses administered to participants